7Shah DI,Singh M.Involvement of Rho kinase in experimental vascular endothelial dysfunction[J].Mol Cell Biochem,2006 ;283(1-2):191-9.
8Wettschureck N,Offermanns S.Rho/Rho -kinase mediated signaling in physiology and pathophysiology[J].J Mol Med,2002 ;80:629-38.
9Hitomi A,Satoh S,Ikegaki I,et al.Hemorheological abnormalities in experimental cerebral ischemia and effects of protein kinase inhibitor on blood fluidity[J].Life Sci,2000 ;67 (16):1929-39.
10Rivera P,Ocaranza MP,Lavandero S,et al.Rho kinase activation and gene expression related to vascular remodeling in normotensive rats with high angiotensin Ⅰ converting enzyme levels[J].Hypertension,2007 ;50 (4):792-8.
3Satoh S,Toshima Y,Ikegaki I,et al.Wide therapeutic time widow for fasudil neuroprotection against ischemia-induced delayed neuronal death in gerbils[J].Brain Res,2007;1128(1):175-80.
4Rikitake Y,Kim HH,Huang Z,et al.Inhibition of Rho kinase (ROCK)leads to increased cerebral blood flow and stroke protection[J].Stroke,2005;36(10):2251-7.
5Shah DI,Singh M.Involvement of Rho-kinase in experimental vascular endothelial dysfunction[J].Mol Cell Biochem,2006;283(1-2):191-9.
6Nohria A,Grunert ME,Rikitake Y,et al.Rho kinse inhibition improves endothelial function in human subjects with coronary artery disease[J].Circ Res,2006;99(12):1426-32.
7Somlyo AP,Somlyo AV.Ca2+ sensitivity of smooth muscle and nonmuscle myosinⅡ:Modulated by G proteins,kinases,and myosin phosphatase[J].Physiol Rev,2003;83(4):1325-58.
8Wettschureck N,Offermanns S.Rho/Rho-kinase mediated signaling in physiology and pathophysiology[J].J Mol Med,2002;80(10):629-38.
9Satoh S,Utsunomiya T,Tsurui K,et al.Pharmacological profile of hydroxy fasudil as a selective Rho kinase inhibitor on ischemic brain damage[J].Life Sci,2001;69(12):1441-53.
10Hara M,Takayasu M,Watanabe K,et al.Protein kinase inhibition by fasudil hydrochloride promotes neurological recovery after spinal cord injury in rats[J].J Neurosurg Spine,2000;93(1 Suppl):94-101.
4Rice JE 3rd, Vannucci RC, Brierley JB. The influence of immaturityon hypoxic - ischemic brain damage in the rat [ J ]. Ann Neurol, 1981,9(2) :131 - 141.
5Wang F, Liang Z, I-Iou Q, et al. Nogo - A is involved in secondary axonal degeneration of thalamus in hypertensive rats with focal corti- cal infarction [ J ]. Neurosci Lett,2007,417 ( 3 ) :255 - 260.
6Craveiro LM, Hakkoum D, Weinmann O, et al. Neutralization of the membrane protein Nogo - A enhances growth and reactive sprouting in established organotypic hippocampal slice cultures[J]. EurJ Neu- rosci ,2008,28 (9) : 1808 - 1824.
7Breitenlechner C, Gassel M, Hidaka H, et al. Protein kinase A in complex with Rho - kinase inhibitors Y - 27632, Fasudil, and H - 1152P : structural basis of selectivity [ J ]. Structure, 2003,11 ( 12 ) : 1595 - 1607.
8Satoh S, Utsunomiya T, Tsurui K, et al. Pharmacological profile of hydroxy fasudil as a selective rho kinase inhibitor on ischemic brain damage[ J]. Life Sci,2001,69(12) :1441 - 1453.
